A meta-analysis in the journal Pediatrics found that the risk of serious asthma-related episodes was higher among children using long-acting beta 2-adrenergic receptor agonists. The highest composite event incidence difference was found in children ages 4 to 11 years old with 30.4 asthma events per 1,000 patient years, researchers said.

Related Summaries